EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Immune abnormalities in IgA nephropathy

Micaela Gentile, Luis Sanchez-Russo, Leonardo V Riella, Alberto Verlato, Joaquin Manrique, Simona Granata, Enrico Fiaccadori, Francesco Pesce, Gianluigi Zaza, Paolo Cravedi

Clinical Kidney Journal · 30.06.2023 · 16 (7) · 1059-1070

DOI: 10.1093/ckj/sfad025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Kidney Journal, online erschienen am 08.02.2023. Verfasst von Micaela Gentile und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, NY, USA. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin A (IgA) nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and it is characterized by mesangial IgA deposition. Asymptomatic hematuria with various degrees of proteinuria is the most common clinical presentation and up to 20%–40% of patients develop end-stage kidney disease within 20 years after disease onset. The pathogenesis of IgAN involves four sequential processes known as the “four-hit hypothesis” which starts with the production of a galactose-deficient IgA1 (gd-IgA1), followed by the formation of anti-gd-IgA1 IgG or IgA1 autoantibodies and immune complexes that ultimately deposit in the glomerular mesangium, leading to inflammation and injury. Although several key questions about the production of gd-IgA1 and the formation of anti-gd-IgA1 antibodies remain unanswered, a growing body of evidence is shedding light on the innate and adaptive immune mechanisms involved in this complex pathogenic process. Herein, we will focus on these mechanisms that, along with genetic and environmental factors, are thought to play a key role in disease pathogenesis.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathyadaptive immunitygalactose-deficient IgA1innate immunity

Autor:innen und Institutionen

  • Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, NY, USA.
  • UO Nefrologia, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy.
  • Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Nephrology Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Nephrology, Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy.
  • Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari "A. Moro", Bari, Italy.

Zitieren

APA

Gentile, M., Sanchez-Russo, L., Riella, L. V., Verlato, A., Manrique, J., Granata, S., Fiaccadori, E., Pesce, F., Zaza, G., & Cravedi, P. (2023). Immune abnormalities in IgA nephropathy. Clinical Kidney Journal, 16(7), 1059-1070. https://doi.org/10.1093/ckj/sfad025

Vancouver

Gentile M, Sanchez-Russo L, Riella LV, Verlato A, Manrique J, Granata S, et al. Immune abnormalities in IgA nephropathy. Clinical Kidney Journal. 2023;16(7):1059-1070. doi:10.1093/ckj/sfad025

BibTeX
@article{Gentile2023,
  author = {Gentile, Micaela and Sanchez-Russo, Luis and Riella, Leonardo V and Verlato, Alberto and Manrique, Joaquin and Granata, Simona and Fiaccadori, Enrico and Pesce, Francesco and Zaza, Gianluigi and Cravedi, Paolo},
  title = {Immune abnormalities in IgA nephropathy},
  journal = {Clinical Kidney Journal},
  year = {2023},
  volume = {16},
  number = {7},
  pages = {1059--1070},
  doi = {10.1093/ckj/sfad025}
}
Kostenlos starten →